Your browser doesn't support javascript.
loading
Investigation of the incidence of immunisation stress-related response following COVID-19 vaccination in healthcare workers.
Takano, Tomonori; Hirose, Masanori; Yamasaki, Yukitaka; Hara, Masatoshi; Okada, Tomoyuki; Kunishima, Hiroyuki.
Afiliação
  • Takano T; Department of Infectious Disease, St. Marianna University School of Medicine, Kanagawa, Japan.
  • Hirose M; Division of General Internal Medicine, St. Marianna University School of Medicine, Kanagawa, Japan.
  • Yamasaki Y; Department of Infectious Disease, St. Marianna University School of Medicine, Kanagawa, Japan.
  • Hara M; Division of Cardiology and Health Service Centre, Department of Internal Medicine, St. Marianna University School of Medicine, Kanagawa, Japan.
  • Okada T; Department of Otolaryngology and Health Service Centre, St. Marianna University School of Medicine, Kanagawa, Japan.
  • Kunishima H; Department of Infectious Disease, St. Marianna University School of Medicine, Kanagawa, Japan. Electronic address: h2kuni@marianna-u.ac.jp.
J Infect Chemother ; 28(6): 735-740, 2022 Jun.
Article em En | MEDLINE | ID: mdl-35190259
ABSTRACT

INTRODUCTION:

Safe vaccination worldwide is critical to end the coronavirus disease 2019 (COVID-19) pandemic. We aimed to evaluate adverse reactions to vaccination using a web-based questionnaire and examine the risk factors for the occurrence of immunisation stress-related response (ISRR).

METHODS:

We conducted a questionnaire survey using Google Form® among the employees of St. Marianna University Hospital who had received the COVID-19 vaccine between April 2021 and May 2021, 1 week after the first and second vaccinations. We developed and used a questionnaire to identify individuals with ISRR according to the World Health Organization diagnostic criteria. A generalised linear mixed model was constructed with ISRR onset as the dependent variable, subjects as the random factor, and each parameter as a fixed factor. A multivariate model was constructed using the forced imputation method with factors that were significant in the univariate analysis.

RESULTS:

We enrolled 2,073 and 1,856 respondents in the first and second questionnaire surveys, respectively. Fifty-five and 33 ISRR cases were identified in the first and second vaccinations, respectively. In the univariate analysis, strong pre-vaccination anxiety (odds ratio [OR], 2.3; 95% confidence interval [CI], 1.30-4.12, p = 0·004) and history of allergy (OR, 1.6; 95% CI, 1.14-2.24, p = 0·007) were significant risk factors. Multivariate analysis also showed that strong pre-vaccination anxiety (OR, 2.1; 95% CI, 1.15-3.80, p = 0.016) and history of allergy (OR, 1.5; 95% CI, 1.09-2.15, p = 0.014) were significant risk factors.

CONCLUSIONS:

Confirmation of allergy prior to vaccination and subsequent action are essential for addressing ISRR.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 / Hipersensibilidade Tipo de estudo: Incidence_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 / Hipersensibilidade Tipo de estudo: Incidence_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article